New shot for obesity shows promise in early trial
NCT ID NCT06679959
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new injectable drug called ASC30 in 115 adults with obesity. The goal was to check its safety, how the body processes it, and its effect on weight. Participants received either the drug or a placebo, and researchers monitored side effects and weight changes over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ASC30 injection
What this could lead to
If successful, this could lead to a new injectable medication for weight management in people with obesity.
What could go wrong
This is an early-phase trial (phase I/IIa) with only 115 participants, so results may not apply broadly. Safety and effectiveness are still being tested, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ascletis clinical site
San Antonio, Texas, 78209, United States